Advertisement
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
This site complies with the HONcode standard for trustworthy health information: verify here .
Susan Hasty, Publisher Table of Contents . . . March 31st, 2004 Non-Subscriber - Summaries Only Related Areas: Other Issues in Medical Device Business Week | Other Publications
AXM Pharma, Inc. - American Stock Exchange lists common stock of generic drugs companyAastrom Biosciences, Inc. - Biosciences company updates stock plan, gets patentAcadia Pharmaceuticals, Inc. - Pharmaceutical company files registration statement for IPOAlexion Pharmaceuticals, Inc. - Pharmaceutical company reports loss of $0.85 per shareAlnylam Pharmaceuticals, Inc. - Pharmaceutical company files for initial public offeringAlpharma, Inc. - Generic drug maker reports earnings of $0.32 per shareAmrad Corporation, Ltd. - Australian biotech company receives second U.S. $3M milestone paymentAnadys Pharmaceuticals, Inc. - Promotion, appointment of regulatory affairs post reported at drug firmAphton Corporation - Biotech company announces exercise of underwriters' over-allotment optionAtrix Laboratories, Inc. - Drug delivery company reports improved financial resultsAutoImmune, Inc. - Biotech company received Nasdaq delisting noticeAvanir Pharmaceuticals - NIH grant awarded to expand development of antianthrax antibodiesBain & Company - Americans might be getting better deal on pharmaceuticals than EuropeansBiogen Idec, Inc. - Biotech company reports fourth quarter earnings per share of $0.24aaiPharma Inc. - Pharmaceutical company enters agreement to sell MVI product business3M - FDA approval granted for immune response modifier for precancerous skin lesionsAdolescent Health - Study links teens' "sense of self" to alcohol, drug use, and sexAgencourt Bioscience Corp. - Protein-protein interaction map of virulence-related genes publishedAgilent Technologies, Inc. - Firm combines gene expression, proteomics and reagents businessesAlveolus, Inc. - Stent maker receives regulatory clearance for benign indicationAmerica's Health Insurance Plans - Healthcare lobby group changes nameAmerican Medical Systems Holdings - Device firm names new members of management, boardAnacor Pharmaceuticals - Plattner named head of research at anti-infectives pharmaceutical firmAnkara University - Tumor angiogenesis has no predictive value for epithelial ovarian cancerAntigen Express - Generex developing kit for early detection of type 1 diabetes in young childrenAssisted Reproduction - Study to explore use of PGD in lowering multiple birth ratesAstraZeneca - Group seeks ban of anticholesterol drugAutonomous University of Nuevo Leon - Agents derived from Central American medicine plants have antiprotozoal activityAventis Pasteur, Paris - A-beta antibody levels not changed in patients with Alzheimer diseaseAvian Influenza - Avian flu threat prompts poultry group to cancel banquetAxis Shield - Detecting vitamin B12 deficiency prevents anemia and memory loss
Baskent University, Ankara - Percutaneous dilational tracheotomy is effective in solid-organ transplantationBaxter Healthcare S.A. - Marketing authorization granted from EC for AdvateBio-Rad Laboratories, Inc. - Assets of Hematronix purchased by diagnostics services companyBioTrove, Inc. - Carroll named chief business officer at firm developing nanofluidic systemsBioVisioN AG - Biotech firm grants non-exclusive license on its DPD-process to RocheBiocompare, Inc. - RNAi, siRNA educational website launchedBiocoral, Inc. - Tissue engineering company announces approval of Canadian patentBiolog, Inc. - Additional patent granted on phenotype microarray technologyBiovail Corporation - Wellbutrin maker provides updated 2004 guidanceBlue Cross of California - Insurer offers new 3500 Deductible PPO Plan with no copays, coinsuranceBoston University - Diet, avoidance of smoking are primary ways for women to prevent heart diseaseBreast Cancer - Black women in U.S. more likely to have delayed diagnosis, treatmentBreast Cancer - Study: Self exam increases women's concerns, has no effect on mortalityBristol Myers Squibb Co. - Selective inhibitors of mitochondrial F1 F0 ATP hydrolase synthesizedBristol-Myers Squibb - Agreements inked to develop novel molecular imaging agentsBroad Institute - Molecular Staging provides whole genome amplification technologyBundesforschungsanstalt fur Landwirtschaft - Staphylococcus lentus gene encodes resistance to chloramphenicolBusiness & Finance - Audit criticizes Hawaii Health Department's financial practicesBusiness & Finance - Kaiser achieves operating margin of 3.9%, announces upgradesBusiness & Finance - Network of rehabilitation providers posts $162 million in national claimsBusiness & Finance - South Dakota state agency gets more funds for anti-tobacco effortsCHU Henri Mondor, Creteil - Genitourinary complications of pelvic radiation therapy can be severeCancerVax Corporation - Cancer vaccine maker reports quarterly loss of $11.1MCarrington Laboratories, Inc. - Drug delivery company's revenues up 61%Case Western Reserve University - Effects of P-TEFb on HIV transcription elucidatedCase Western Reserve University - New technique tracks irregular heartbeatsCelgene Corporation - Revlimid receives orphan drug designation by the European CommissionChildren's Hospital of Philadelphia - Common virus may contribute to uncommon bone diseaseChiron Corporation - Deal signed for development of therapeutic antibodies for cancerChonbuk National University - VEGF and proteolytic enzyme show a strong correlation with pleural effusionsCntr. Invest. y Estudios Avanz. IPN, Mexico City - Dengue virus receptor molecules isolated by affinity chromatographyCold Spring Harbor Laboratory - Crucial brain development gene identifiedColumbia University - Impaired AKT1-GSK3 beta signaling plays role in schizophrenia
Return to Top of Page
